Featured Story

  • Illumina readies paid-for BaseSpace tiers for large organizations

    Illumina has detailed how it intends to start generating income from its cloud app platform BaseSpace. The plan includes the creation of two paid-for packages that bundle together assorted features, some of which are targeted specifically at larger organizations.

WuXi NextCODE plans MA hiring spree after landing Qatari deal

WuXi NextCODE has added another country to its growing list of large-scale sequencing projects. Sidra Medical and Research Center, which is involved with the Qatar Genome Project, has turned to WuXi NextCODE for help.

UBiome taps Apple ecosystem to broaden microbiome data-gathering drive

UBiome has become the first for-profit organization to roll out an app for Apple ResearchKit, the tech giant's open-source study platform. The program is combining a ResearchKit-enabled app with uBiome's microbiome test to generate data that may one day support biopharma R&D.

ResearchKit-enabled project sets out to track real-world effectiveness of hep C drugs

When Gilead's Sovaldi and AbbVie's Viekira Pak came to market, physicians had little real-world evidence for either drug on which to base their prescribing decisions. In an attempt to fill this gap and find out what happens to hepatitis C patients between physician visits, Boston Children's Hospital has created an app for Apple ResearchKit.

GSK finds 21M mentions of its drugs in trawl of social media

GlaxoSmithKline has provided a glimpse at just how much information about the real-world use of drugs is online. In a trawl of Facebook and Twitter, the Big Pharma found 21 million mentions of its products--and the data have already led to the recall of a GSK product.

NIH gives UCSF $10M to build mobile data collection platform

The University of California, San Francisco (UCSF) has snagged $9.75 million to build a platform for the remote collection of research data. UCSF will use the cash to build out its mobile data gathering toolkit, giving it the capabilities to support large-scale, geographically-dispersed research programs.


From Our Sister Sites


Moderna Therapeutics' top scientist has quietly left the much-discussed company after two years at the helm of its R&D operation, walking away from a cash-flush biotech with big ambitions.


A new company spun out of Harvard University's Wyss Institute raised $5.15 million in Series A cash to develop a technology its founders say can generate images of unprecedented resolution, creating a new avenue for diagnostics and drug discovery.